Aspen Neuroscience Revenue and Competitors
Estimated Revenue & Valuation
- Aspen Neuroscience's estimated annual revenue is currently $21.2M per year.
- Aspen Neuroscience's estimated revenue per employee is $155,000
- Aspen Neuroscience's total funding is $224M.
Employee Data
- Aspen Neuroscience has 137 Employees.
- Aspen Neuroscience grew their employee count by 19% last year.
Aspen Neuroscience's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Senior Scientist | Reveal Email/Phone |
Aspen Neuroscience Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Aspen Neuroscience?
Aspen is developing enabling technologies for patient-specific induced pluripotent stem cell-based therapies.
keywords:N/A
$224M
Total Funding
137
Number of Employees
$21.2M
Revenue (est)
19%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Aspen Neuroscience News
The Trial-Ready Cohort Study will offer data for the planned Phase I/IIa trial of ANPD001. Aspen Neuroscience has announced plans to commence a...
SAN DIEGO, April 11, 2022 /PRNewswire/ -- Aspen Neuroscience, Inc., a private biotechnology company developing induced pluripotent stem cell...
SAN DIEGO, May 5, 2021 /PRNewswire/ -- Aspen Neuroscience, a private biotechnology company developing the first autologous neuron replacement therapies to treat Parkinson's disease (PD), announced today that Andres Bratt-Leal, PhD, has been promoted to Senior Vice President of Research & Devel ...
Aspen Neuroscience, a biotechnology company developing the first autologous neuron replacement therapy for treating Parkinson’s announced it raised $70 million Aspen Neuroscience, a biotechnology company developing the first autologous neuron replacement therapy for treating Parkinson’s disease ...
San Diego-based Aspen Neuroscience, a biotechnology company developing treatments for Parkinson disease, said it has raised $70M in a Series A funding round. The funding was led by OrbiMed, and also included ARCH Venture Partners, Frazier Healthcare Partners, Domain Associates, Section 32, and S ...
Other Companies in La Jolla
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $28.8M | 137 | -69% | N/A |
#2 | $27.4M | 153 | 31% | N/A |
#3 | $43.6M | 156 | 2% | N/A |
#4 | $7.5M | 156 | 0% | N/A |
#5 | $32.3M | 163 | -20% | N/A |